Status:
UNKNOWN
A Prospective Study of a New Immunological Fecal Occult Blood Test
Lead Sponsor:
National Institute of Gastroenterology, Cuba
Conditions:
Colonoscopy
Occult Blood
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the investigators study is to evaluate the diagnostic ability of a new immunological fecal occult blood test in Cuban patients undergoing colonoscopy .
Detailed Description
Colorectal cancer is a major cause of cancer deaths in many countries. Therefore, the importance of screening for the early detection of colorectal cancer is evident. Fecal occult blood screening is p...
Eligibility Criteria
Inclusion
- Patients (men or women) that are \>18 years of age referred to colonoscopy.
Exclusion
- Visible rectal bleeding
- Known diagnosis of inflammatory bowel disease
- Hematuria
- Menstruation at the time of obtaining a stool specimen
- Patients taking medication such as non steroids anti inflammatory drugs and anticoagulants
Key Trial Info
Start Date :
October 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2010
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00959491
Start Date
October 1 2009
End Date
November 1 2010
Last Update
October 20 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Gastroenterology
Havana, La Habana, Cuba, 10400